Safety and Efficacy of Different Oral Doses of BAY94-8862 in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Nephropathy
Clinical trial NCT01874431 · COMPLETED
Trial details
- NCT number
- NCT01874431
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-06-12
- Primary completion
- 2014-07-09
- Enrollment
- 823
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.